CSRC approves Beixin Life's application for IPO on the Science and Technology Innovation Board.

According to the financial news app 36kr, on December 18th, the China Securities Regulatory Commission issued a letter of approval for the initial public offering of shares by Shenzhen Beixin Life Science and Technology Co., Ltd. It is reported that Beixin Life Science plans to list on the Science and Technology Innovation Board of the Shanghai Stock Exchange, with China International Capital Corporation as the sponsor, and plans to raise 952 million yuan.